Europe Antineoplastic Agents Market Report to 2021

November 2016 | 107 pages | ID: EF478FC018AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antineoplastic Agents

Revenue, means the sales value of Antineoplastic Agents

This report studies sales (consumption) of Antineoplastic Agents in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Antineoplastic Agents in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Alkylating Agent
• Anti-metabolic Tumor Drugs
• Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
• Others

Split by applications, this report focuses on sales, market share and growth rate of Antineoplastic Agents in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

1 ANTINEOPLASTIC AGENTS OVERVIEW

1.1 Product Overview and Scope of Antineoplastic Agents
1.2 Classification of Antineoplastic Agents
  1.2.1 Alkylating Agent
  1.2.2 Anti-metabolic Tumor Drugs
  1.2.3 Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
  1.2.4 Others
1.3 Applications of Antineoplastic Agents
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Antineoplastic Agents Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Antineoplastic Agents (2011-2021)
  1.5.1 Europe Antineoplastic Agents Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Antineoplastic Agents Sales and Growth Rate (2011-2021)
  1.5.3 Europe Antineoplastic Agents Revenue and Growth Rate (2011-2021)

2 EUROPE ANTINEOPLASTIC AGENTS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Antineoplastic Agents Market Competition by Manufacturers
  2.1.1 Europe Antineoplastic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Antineoplastic Agents Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antineoplastic Agents (Volume and Value) by Type
  2.2.1 Europe Antineoplastic Agents Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
2.3 Europe Antineoplastic Agents (Volume and Value) by Regions
  2.3.1 Europe Antineoplastic Agents Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Antineoplastic Agents Revenue and Market Share by Regions (2011-2021)
2.4 Europe Antineoplastic Agents (Volume) by Application

3 GERMANY ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Antineoplastic Agents Sales and Value (2011-2021)
  3.1.1 Germany Antineoplastic Agents Sales and Growth Rate (2011-2021)
  3.1.2 Germany Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Antineoplastic Agents Sales Price Trend (2011-2021)
3.2 Germany Antineoplastic Agents Sales and Market Share by Manufacturers
3.3 Germany Antineoplastic Agents Sales and Market Share by Type
3.4 Germany Antineoplastic Agents Sales and Market Share by Applications

4 UK ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

4.1 UK Antineoplastic Agents Sales and Value (2011-2021)
  4.1.1 UK Antineoplastic Agents Sales and Growth Rate (2011-2021)
  4.1.2 UK Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  4.1.3 UK Antineoplastic Agents Sales Price Trend (2011-2021)
4.2 UK Antineoplastic Agents Sales and Market Share by Manufacturers
4.3 UK Antineoplastic Agents Sales and Market Share by Type
4.4 UK Antineoplastic Agents Sales and Market Share by Applications

5 FRANCE ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

5.1 France Antineoplastic Agents Sales and Value (2011-2021)
  5.1.1 France Antineoplastic Agents Sales and Growth Rate (2011-2021)
  5.1.2 France Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  5.1.3 France Antineoplastic Agents Sales Price Trend (2011-2021)
5.2 France Antineoplastic Agents Sales and Market Share by Manufacturers
5.3 France Antineoplastic Agents Sales and Market Share by Type
5.4 France Antineoplastic Agents Sales and Market Share by Applications

6 ITALY ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Antineoplastic Agents Sales and Value (2011-2021)
  6.1.1 Italy Antineoplastic Agents Sales and Growth Rate (2011-2021)
  6.1.2 Italy Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Antineoplastic Agents Sales Price Trend (2011-2021)
6.2 Italy Antineoplastic Agents Sales and Market Share by Manufacturers
6.3 Italy Antineoplastic Agents Sales and Market Share by Type
6.4 Italy Antineoplastic Agents Sales and Market Share by Applications

7 RUSSIA ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Antineoplastic Agents Sales and Value (2011-2021)
  7.1.1 Russia Antineoplastic Agents Sales and Growth Rate (2011-2021)
  7.1.2 Russia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Antineoplastic Agents Sales Price Trend (2011-2021)
7.2 Russia Antineoplastic Agents Sales and Market Share by Manufacturers
7.3 Russia Antineoplastic Agents Sales and Market Share by Type
7.4 Russia Antineoplastic Agents Sales and Market Share by Applications

8 SPAIN ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Antineoplastic Agents Sales and Value (2011-2021)
  8.1.1 Spain Antineoplastic Agents Sales and Growth Rate (2011-2021)
  8.1.2 Spain Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Antineoplastic Agents Sales Price Trend (2011-2021)
8.2 Spain Antineoplastic Agents Sales and Market Share by Manufacturers
8.3 Spain Antineoplastic Agents Sales and Market Share by Type
8.4 Spain Antineoplastic Agents Sales and Market Share by Applications

9 EUROPE ANTINEOPLASTIC AGENTS MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Antineoplastic Agents Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Antineoplastic Agents Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Antineoplastic Agents Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Antineoplastic Agents Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Antineoplastic Agents Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Antineoplastic Agents Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Antineoplastic Agents Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Antineoplastic Agents Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Antineoplastic Agents Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
9.10 Abbvie
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Antineoplastic Agents Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)
9.11 AMGen
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Antineoplastic Agents Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Antineoplastic Agents Sales, Revenue, Price of AMGen (2015 and 2016)
9.12 Teva Pharmaceutical Industries Ltd.
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Antineoplastic Agents Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Antineoplastic Agents Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
9.13 Bayer AG
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Antineoplastic Agents Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Antineoplastic Agents Sales, Revenue, Price of Bayer AG (2015 and 2016)
9.14 Bristol-Myers Squibb
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Antineoplastic Agents Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Antineoplastic Agents Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
9.15 Astellas Pharma
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Antineoplastic Agents Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Antineoplastic Agents Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
9.16 Daiichi Sankyo
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Antineoplastic Agents Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Antineoplastic Agents Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)

10 ANTINEOPLASTIC AGENTS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Antineoplastic Agents Technology Analysis
10.2 Antineoplastic Agents Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antineoplastic Agents
Table Classification of Antineoplastic Agents
Figure Europe Sales Market Share of Antineoplastic Agents by Types in 2015
Figure Alkylating Agent Picture
Figure Anti-metabolic Tumor Drugs Picture
Figure Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives Picture
Figure Others Picture
Table Applications of Antineoplastic Agents
Figure Europe Sales Market Share of Antineoplastic Agents by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure Germany Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure France Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure UK Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Italy Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Spain Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Russia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table Europe Antineoplastic Agents Sales, Revenue and Price (2011-2021)
Figure Europe Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Europe Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table Europe Antineoplastic Agents Sales of Key Manufacturers (2015 and 2016)
Table Europe Antineoplastic Agents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antineoplastic Agents Sales Share by Manufacturers
Figure 2016 Antineoplastic Agents Sales Share by Manufacturers
Table Europe Antineoplastic Agents Revenue by Manufacturers (2015 and 2016)
Table Europe Antineoplastic Agents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antineoplastic Agents Revenue Share by Manufacturers
Table 2016 Europe Antineoplastic Agents Revenue Share by Manufacturers
Table Europe Antineoplastic Agents Sales and Market Share by Type (2011-2021)
Table Europe Antineoplastic Agents Sales Share by Type (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Type (2011-2021)
Figure Europe Antineoplastic Agents Sales Growth Rate by Type (2011-2021)
Table Europe Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
Table Europe Antineoplastic Agents Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Type (2011-2021)
Figure Europe Antineoplastic Agents Revenue Growth Rate by Type (2011-2021)
Table Europe Antineoplastic Agents Sales and Market Share by Regions (2011-2021)
Table Europe Antineoplastic Agents Sales Share by Regions (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Regions (2011-2021)
Figure Europe Antineoplastic Agents Sales Growth Rate by Regions (2011-2021)
Table Europe Antineoplastic Agents Revenue and Market Share by Regions (2011-2021)
Table Europe Antineoplastic Agents Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Regions (2011-2021)
Figure Europe Antineoplastic Agents Revenue Growth Rate by Regions (2011-2021)
Table Europe Antineoplastic Agents Sales and Market Share by Application (2011-2021)
Table Europe Antineoplastic Agents Sales Share by Application (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Application (2011-2021)
Figure Europe Antineoplastic Agents Sales Growth Rate by Application (2011-2021)
Figure Germany Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Germany Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Germany Antineoplastic Agents Sales Price Trend (2011-2021)
Table Germany Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Germany Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Germany Antineoplastic Agents Sales by Type (2015 and 2016)
Table Germany Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Germany Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Germany Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure UK Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure UK Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure UK Antineoplastic Agents Sales Price Trend (2011-2021)
Table UK Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table UK Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table UK Antineoplastic Agents Sales by Type (2015 and 2016)
Table UK Antineoplastic Agents Market Share by Type (2015 and 2016)
Table UK Antineoplastic Agents Sales by Applications (2015 and 2016)
Table UK Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure France Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure France Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure France Antineoplastic Agents Sales Price Trend (2011-2021)
Table France Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table France Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table France Antineoplastic Agents Sales by Type (2015 and 2016)
Table France Antineoplastic Agents Market Share by Type (2015 and 2016)
Table France Antineoplastic Agents Sales by Applications (2015 and 2016)
Table France Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Italy Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Italy Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Italy Antineoplastic Agents Sales Price Trend (2011-2021)
Table Italy Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Italy Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Italy Antineoplastic Agents Sales by Type (2015 and 2016)
Table Italy Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Italy Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Italy Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Russia Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Russia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Russia Antineoplastic Agents Sales Price Trend (2011-2021)
Table Russia Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Russia Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Russia Antineoplastic Agents Sales by Type (2015 and 2016)
Table Russia Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Russia Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Russia Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Spain Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Spain Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Spain Antineoplastic Agents Sales Price Trend (2011-2021)
Table Spain Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Spain Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Spain Antineoplastic Agents Sales by Type (2015 and 2016)
Table Spain Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Spain Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Spain Antineoplastic Agents Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)
...